Nikhil Lalwani - Net Worth and Insider Trading

Nikhil Lalwani Net Worth

The estimated net worth of Nikhil Lalwani is at least $24 Million dollars as of 2024-06-13. Nikhil Lalwani is the PRESIDENT & CEO of ANI Pharmaceuticals Inc and owns about 377,505 shares of ANI Pharmaceuticals Inc (ANIP) stock worth over $24 Million. Details can be seen in Nikhil Lalwani's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nikhil Lalwani has not made any transactions after 2024-05-14 and currently still holds the listed stock(s).

Transaction Summary of Nikhil Lalwani

To

Nikhil Lalwani Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nikhil Lalwani owns 1 companies in total, including ANI Pharmaceuticals Inc (ANIP) .

Click here to see the complete history of Nikhil Lalwani’s form 4 insider trades.

Insider Ownership Summary of Nikhil Lalwani

Ticker Comapny Transaction Date Type of Owner
ANIP ANI Pharmaceuticals Inc 2024-05-14 director & PRESIDENT & CEO

Nikhil Lalwani Latest Holdings Summary

Nikhil Lalwani currently owns a total of 1 stock. Nikhil Lalwani owns 377,505 shares of ANI Pharmaceuticals Inc (ANIP) as of May 14, 2024, with a value of $24 Million.

Latest Holdings of Nikhil Lalwani

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANIP ANI Pharmaceuticals Inc 2024-05-14 377,505 64.26 24,258,471

Holding Weightings of Nikhil Lalwani


Nikhil Lalwani Form 4 Trading Tracker

According to the SEC Form 4 filings, Nikhil Lalwani has made a total of 4 transactions in ANI Pharmaceuticals Inc (ANIP) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in ANI Pharmaceuticals Inc is the sale of 16,669 shares on May 14, 2024, which brought Nikhil Lalwani around $1 Million.

Insider Trading History of Nikhil Lalwani

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nikhil Lalwani Trading Performance

GuruFocus tracks the stock performance after each of Nikhil Lalwani's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nikhil Lalwani is -7.02%. GuruFocus also compares Nikhil Lalwani's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nikhil Lalwani within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nikhil Lalwani's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nikhil Lalwani

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.29 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 25.8 LIMIT LIMIT LIMIT LIMIT LIMIT

Nikhil Lalwani Ownership Network

Ownership Network List of Nikhil Lalwani

No Data

Ownership Network Relation of Nikhil Lalwani

Insider Network Chart

Nikhil Lalwani Owned Company Details

What does ANI Pharmaceuticals Inc do?

Who are the key executives at ANI Pharmaceuticals Inc?

Nikhil Lalwani is the director & PRESIDENT & CEO of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include SVP & GENERICS Ori Gutwerg , Vice President and CFO Stephen P. Carey , and SVP - CORP. DEV. & STRATEGY Chad Gassert .

ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary

Over the past 18 months, Nikhil Lalwani made 3 insider transaction in ANI Pharmaceuticals Inc (ANIP) with a net sale of 130,208. Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 676,190 shares made by Muthusamy Shanmugam , a net sale of 180,000 shares made by Chad Gassert , and a net sale of 1,750 shares made by Meredith Cook .

In summary, during the past 3 months, insiders sold 189,154 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 189,154 shares. During the past 18 months, 1,290,012 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,290,012 shares.

ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ANI Pharmaceuticals Inc Insider Transactions

No Available Data

Nikhil Lalwani Mailing Address

Above is the net worth, insider trading, and ownership report for Nikhil Lalwani. You might contact Nikhil Lalwani via mailing address: C/o Ani Pharmaceuticals, Inc., 210 Main Street, Baudette Mn 56623.

Discussions on Nikhil Lalwani

No discussions yet.